comparemela.com
  1. Home
  2. Live Updates
  3. Agreement Covers All Existing Territories - Breaking News

Latest Breaking News On - Agreement covers all existing territories - Page 1 : comparemela.com

Pharmanovia Enters In-Licensing Agreement With Axsome Therapeutics to Market and Further Develop Sunosi (solriamfetol), a First-In-Class Treatment for Excessive Daytime Sleepiness (EDS) in People With Narcolepsy and Obstructive Sleep Apnoea

The Agreement Covers All Existing Territories in Europe and Any Future Launches Across the Region Pharmanovia Will Also Lead All Activities to Support the Launch of Sunosi (solriamfetol) Across Middle

Dennis riedlHerriot tabuteauJames burtAlison dysonAxsome therapeutics incAgreement covers all existing territoriesAny future launches acrossWill also lead all activitiesAcross middle east north africaAll ongoingFuture clinical studiesAxsome therapeuticsControlled trialExcessive daytime sleepinessSubgroups adherent

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.